This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Leon Berard, Centre National De La Recherche Scientifique. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 39 
1 out of 5,383 
Years Active: 2021
Title: Julien Fitamant - Innovator in Cancer Research
Introduction
Julien Fitamant is a notable inventor based in Lyon, France. He has made significant contributions to the field of cancer research, particularly in the development of methods for screening anti-cancer compounds. Although he currently holds no granted patents, his work is influential in the scientific community.
Latest Patent Applications
Julien Fitamant's latest patent application is titled "Screening for Anti-Cancer Compounds Using Netrin-1 Activity." This invention relates to an in vitro method for screening anti-cancer compounds based on their ability to interact with the netrin-1 receptor and/or inhibit the dimerization of the intracellular domain of the netrin-1 receptor expressed in tumor cells. The invention also includes methods for predicting the presence of metastatic or aggressive cancer and determining the efficiency of anti-cancer treatments by measuring the expression level of netrin-1. Additionally, it encompasses kits and compounds for treating cancers, such as metastatic breast cancer, associated with the overexpression of netrin-1 by tumor cells.
Conclusion
Julien Fitamant's innovative work in cancer research highlights the importance of developing new methods for screening anti-cancer compounds. His contributions, although not yet patented, pave the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile